A large biopharma company was conducting a Phase IV trial of an approved biologic to understand its potential impact on sleep disturbance associated with asthma.
Toward the end of the three-year trial, the Science 37 Direct-to-Patient Site was deployed to test a decentralized clinical trial model with home-based spirometry. Learn how Science 37 provided:
Download the case study to explore the power of a Direct-to-Patient Site for respiratory research today!